Weiss Asset Management’s Sprott Physical Gold and Silver Trust CEF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125M Buy
3,099,716
+1,360,216
+78% +$63.5M 1.31% 13
2026
Q1
$83M Buy
+1,739,500
New +$89M 1.4% 15
2019
Q3
Sell
-45,360
Closed -$600K 388
2019
Q2
$600K Sell
45,360
-2,059,547
-98% -$25.7M 0.04% 142
2019
Q1
$26.1M Buy
2,104,907
+1,679,597
+395% +$21.4M 2.04% 12
2018
Q4
$5.33M Sell
425,310
-2,291,887
-84% -$27.2M 0.38% 64
2018
Q3
$31.7M Buy
2,717,197
+1,911,520
+237% +$22.9M 2.44% 9
2018
Q2
$10.1M Sell
805,677
-8,761,752
-92% -$116M 1% 31
2018
Q1
$126M Buy
9,567,429
+1,884,700
+25% +$25.2M 10.18% 1
2017
Q4
$103M Buy
+7,682,729
New +$101M 8.97% 2

Other funds holding CEF

Weiss Asset Management's CEF Position: Q2 2026 in Review

Weiss Asset Management increased its Sprott Physical Gold and Silver Trust (CEF) stake by 78% in Q2 2026, buying an estimated $63.5M and bringing the position to 3,099,716 shares worth $125M. The position accounts for 1.31% of the portfolio, ranked #13.

Weiss Asset Management first reported a position in CEF in Q4 2017 and has held it in 9 quarters since. The position peaked at $126M in Q1 2018. 447 funds tracked by Wall St. Rank hold CEF as of Q2 2026.

  • Weiss Asset Management held 3,099,716 shares of Sprott Physical Gold and Silver Trust worth $125M as of Q2 2026.
  • Weiss Asset Management bought 1,360,216 Sprott Physical Gold and Silver Trust shares in Q2 2026, an estimated $63.5M.
  • Sprott Physical Gold and Silver Trust made up 1.31% of Weiss Asset Management's portfolio in Q2 2026, its #13 holding.
  • Weiss Asset Management first reported a position in Sprott Physical Gold and Silver Trust in Q4 2017 and has held it in 9 quarters since.
  • Weiss Asset Management's Sprott Physical Gold and Silver Trust position peaked at $126M in Q1 2018.
  • 447 funds tracked by Wall St. Rank held Sprott Physical Gold and Silver Trust as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.